论文部分内容阅读
目的探讨糖尿病肾病终末期患者的血液透析时机及并发症的防治。方法观察糖尿病终末期肾病(ESDN)及非糖尿病终末期肾病(NOR-ESDN)血液透析患者首次透析前血尿素氮、肌酐以及透析期间并发症、存活率。结果糖尿病终末期肾病血透患者的存活率较非糖尿病终末期肾病血透患者短,心血管并发症及感染并发症较NOR-ESDN血透患者发生多。结论 ESDN患者透析时机的选择应早于NOR-ESDN患者,应积极预防和控制并发症。
Objective To investigate the timing of hemodialysis and prevention and treatment of end-stage diabetic nephropathy. Methods Blood urea nitrogen, creatinine before dialysis and complication and survival rate during dialysis were measured in patients with end-stage renal disease (ESDN) and non-diabetic end-stage renal disease (NOR-ESDN). Results The survival rate of patients with end-stage renal disease with hemodialysis was shorter than that of non-diabetic patients with end stage renal disease. The incidence of cardiovascular complications and complications was higher than that of patients with NOR-ESDN hemodialysis. Conclusion The timing of dialysis in patients with ESDN should be earlier than that in patients with NOR-ESDN, and should be actively prevented and controlled.